Health Technology Assessment (HTA) refers to the systematic evaluation of properties, effects, and/or impacts of health technology. It is a multidisciplinary process to evaluate the social, economic, organizational and ethical issues of a health intervention or health technology. The main purpose of HTA is to inform health care policy makers about reimbursement /use of health technologies.
- Is it providing added value (for money) compared to what is currently available?
- Which set of patients are going to be benefited the most from this?
We have experience submitting to HTA agencies around the globe, including the United Kingdom (NICE, SMC, AWMSG, JCVI), Republic of Ireland (NCPE), Sweden (TLV), Australia (PBAC), and Canada (CDR). Data extraction of the HTA reports can be done for pharma companies and the guidance provided by various HTA agencies can be analyzed, facilitating the designing and drafting of submissions.
Our HTA monitoring services include:
- Level and subdivide HTA agencies by comparing more than various dimensions describing the maturity of priorities, process and decision-making.
- Compare HTA agencies within and across regions to formulate evidence and access strategy.
- Access various categories of requirements of chosen clinical, economic, process and threshold requirements to develop clinical and economic evidence strategy.
- Provide insight about the various decision drivers and design predictors for rapid reimbursement acceptance.